Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLEAN+ colonoscopy bowel preparation comparison trial
2025-523748-11-00Phase 4Authorised
- Sponsor
- IDIBAPS
- Start
- May 2026
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of polyethylene glycol + citrate + simethicone, sodium picosulfate and simethicone in colorectal cancer (CRC) (2 arms), sponsored by IDIBAPS. Primary endpoint: Adenoma detection rate. Planned start May 2026; status: authorised.
02
Drugs
polyethylene glycol + citrate + simethiconesodium picosulfatesimethicone
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on 2025-523748-11-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-523748-11-00.